Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical characterization of SEP-230864 presented by Sepracor

Oct. 26, 2009

PSN-0041 displays enhanced antidepressant activity over native amylin in preclinical tests

Oct. 26, 2009

Phase I study results encourage further development of anesthetic PF-0713

Oct. 26, 2009

Dienogest exhibits favorable safety profile in the long-term treatment of endometriosis

Oct. 26, 2009

The GnRH antagonist TAK-38 has potential for the treatment of endometriosis

Oct. 23, 2009

AMR-MCH-14 reduces food intake and body fat in preclinical model of obesity

Oct. 23, 2009

Aminophylline reverses midazolam sedation in healthy volunteers

Oct. 23, 2009

Rolapitant similar to ondansetron in treating postoperative nausea and vomiting

Oct. 23, 2009

Non-selective opioid modulator RDC-5768 reduces behavioral effects of drugs of abuse

Oct. 23, 2009

Further clinical data on dapagliflozin presented at the World Diabetes Congress

Oct. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...